Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase-Reference-Cited by-同舟云学术

Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase

Published:2022-02-14 Issue:5 Volume:37 Page:847-854
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Sakurai Toshiyuki¹^ORCID,Akita Yoshihiro¹,Miyashita Haruna¹,Miyazaki Ryosuke¹^ORCID,Maruyama Yuki¹^ORCID,Saito Tomoko¹,Shimada Mariko¹,Yamasaki Takuji¹^ORCID,Arhihiro Seiji²^ORCID,Kato Tomohiro¹,Matsuura Tomokazu³,Ikegami Masahiro⁴,Okayasu Isao⁵,Saruta Masayuki¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine The Jikei University School of Medicine Tokyo Japan

2. Division of Gastroenterology and Hepatology, Department of Internal Medicine The Jikei Katsushika Medical Center Tokyo Japan

3. Department of Laboratory Medicine The Jikei University School of Medicine Tokyo Japan

4. Division of Pathology The Jikei University School of Medicine Tokyo Japan

5. Department of Pathology Kitasato University School of Medicine Sagamihara Kanagawa Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15782

Reference28 articles.

1. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

2. Ulcerative Colitis

3. Ulcerative colitis

4. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission

5. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments;Trends in Pharmacological Sciences;2024-09

2. Recent advances in novel functionalized oral administration therapy for inflammatory bowel diseases;Chinese Science Bulletin;2024-08-01

3. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

4. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond;Diagnostics;2024-06-28

5. Prostaglandin E-major urinary metabolites as a new biomarker for acute mesenteric ischemia;Journal of Trauma and Acute Care Surgery;2024-02-05